United States · FDA National Drug Code directory
Orphenadrine Citrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-0169_a11270c6-fe5e-4cfd-9a1e-f11abb0fe4a0
- Product NDC
- 50090-0169
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- ORPHENADRINE CITRATE
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19980619
- Source listing expiry
- 20271231
Source-listed ingredients
- ORPHENADRINE CITRATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-0) · 50090-0169-0
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-1) · 50090-0169-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-5) · 50090-0169-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →